Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000318154-25-000020
Filing Date
2025-05-02
Accepted
2025-05-01 18:54:46
Documents
82
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q amgn-20250331.htm   iXBRL 10-Q 1842021
2 RULE 13A-14(A) CERTIFICATIONS amgn-ex31_20250331x10xq.htm EX-31 19892
3 SECTION 1350 CERTIFICATIONS amgn-ex32_20250331x10xq.htm EX-32 9547
  Complete submission text file 0000318154-25-000020.txt   9096767

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT amgn-20250331.xsd EX-101.SCH 53440
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT amgn-20250331_cal.xml EX-101.CAL 67486
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT amgn-20250331_def.xml EX-101.DEF 316420
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT amgn-20250331_lab.xml EX-101.LAB 652879
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT amgn-20250331_pre.xml EX-101.PRE 487460
84 EXTRACTED XBRL INSTANCE DOCUMENT amgn-20250331_htm.xml XML 1577013
Mailing Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320
Business Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320 (805)447-1000
AMGEN INC (Filer) CIK: 0000318154 (see all company filings)

EIN.: 953540776 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37702 | Film No.: 25905015
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)